Keywords: ivax, acquires, epilepsy, drug, lilly, corp, entered

IVAX acquires epilepsy drug from Lilly

Article | 08 February 2001

Print This

IVAX Corp has entered into an exclusive agreement with Eli Lilly todevelop and market the latter's AMPA receptor antagonist, talampanel, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in